GE HealthCare Technologies Inc (NASDAQ: GEHC) has a higher price-to-earnings ratio of 23.76x compared to its average ratio. GEHC has 36-month beta value of 1.37. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GEHC is 424.46M, and currently, short sellers hold a 2.99% ratio of that float. The average trading volume of GEHC on July 29, 2024 was 2.82M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GEHC) stock’s latest price update
GE HealthCare Technologies Inc (NASDAQ: GEHC)’s stock price has soared by 1.14 in relation to previous closing price of 80.50. Nevertheless, the company has seen a gain of 0.23% in its stock price over the last five trading days. investopedia.com reported 2024-07-26 that GE HealthCare (GEHC) will report earnings before markets open Wednesday, making it the last of the three former General Electric divisions to report for the quarter after GE Aerospace (GE) and GE Vernova (GEV).
GEHC’s Market Performance
GE HealthCare Technologies Inc (GEHC) has experienced a 0.23% rise in stock performance for the past week, with a 3.30% rise in the past month, and a -5.59% drop in the past quarter. The volatility ratio for the week is 1.72%, and the volatility levels for the past 30 days are at 1.97% for GEHC. The simple moving average for the last 20 days is 2.66% for GEHC’s stock, with a simple moving average of 3.54% for the last 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with Goldman repeating the rating for GEHC by listing it as a “Neutral.” The predicted price for GEHC in the upcoming period, according to Goldman is $87 based on the research report published on May 30, 2024 of the current year 2024.
HSBC Securities, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $100. The rating they have provided for GEHC stocks is “Buy” according to the report published on February 15th, 2024.
UBS gave a rating of “Neutral” to GEHC, setting the target price at $88 in the report published on February 12th of the current year.
GEHC Trading at 3.26% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.84% of loss for the given period.
Volatility was left at 1.97%, however, over the last 30 days, the volatility rate increased by 1.72%, as shares surge +4.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.38% lower at present.
During the last 5 trading sessions, GEHC rose by +0.46%, which changed the moving average for the period of 200-days by +19.67% in comparison to the 20-day moving average, which settled at $79.50. In addition, GE HealthCare Technologies Inc saw 5.30% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Kass-Hout Taha, who sale 3,300 shares at the price of $78.70 back on May 28 ’24. After this action, Kass-Hout Taha now owns 67,300 shares of GE HealthCare Technologies Inc, valued at $259,710 using the latest closing price.
Makela Jan, the CEO, Imaging of GE HealthCare Technologies Inc, sale 66,955 shares at $81.54 during a trade that took place back on May 15 ’24, which means that Makela Jan is holding 63,348 shares at $5,459,511 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.12 for the present operating margin
- 0.41 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.08. The total capital return value is set at 0.1. Equity return is now at value 22.33, with 4.85 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 1.31. The interest coverage ratio of the stock is 4.44.
Currently, EBITDA for the company is 3.51 billion with net debt to EBITDA at 2.15. When we switch over and look at the enterprise to sales, we see a ratio of 2.27. The receivables turnover for the company is 4.85for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.01.
Conclusion
To put it simply, GE HealthCare Technologies Inc (GEHC) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
